Professor Philip BarterDirector
The Heart Research Institute
Professor of Medicine
University of Sydney
Sydney, AUSTRALIA
Professor Barter is President-Elect of the ISA. Professor Barter’s basic research interests are plasma lipids and lipoproteins, specifically high density lipoproteins. His clinical research involves participation in clinical trials. He was a member of the steering committees of the FIELD study and of the TNT Study and was chairman of the steering committee of the ILLUMINATE study. He is currently a member of the steering committee of the DalOutcomes and is co-chair of the DEFINE trial; these are studies of new CETP inhibitors.
Head of Lipid Research Group
Director
. All rights reserved.